Tag Archives: BDNF
Aerobic Exercise and Depression: Re-Reading the Evidence in 2026
Aerobic Exercise and Depression: Re-Reading the Evidence in 2026 A sweeping global review now ranks aerobic exercise alongside first-line pharmacotherapy for depression. A NYC neuropsychiatrist examines what the data actually supports Posted on February 12, 2026 by the PsychiatryNeurology.net Team The … Continue reading →
Posted in Aging, Clinical & Theoretical, Complementary - Alternative Medicine, epigenetics, Fifth Avenue Concierge Medicine, Health, Lifestyle Psychiatry, new treatments, News
|
Tagged aerobic exercise, BDNF, brain longevity, CANMAT guidelines, depression treatment, evidence-based psychiatry, exercise and depression, exercise prescription, healthspan, lifestyle psychiatry, longevity, major depressive disorder, neuropsychiatry, New York psychiatrist, Noetel meta-analysis, NYC neuropsychiatrist, pharmacotherapy comparison, treatment-resistant depression, umbrella review
|
Muscle as Medicine: Skeletal Muscle Mass and 10-Year CVD Risk
The ATTICA study shows that higher skeletal muscle mass predicts lower cardiovascular disease risk over 10 years. A neuropsychiatric analysis of muscle, heart, and brain health. Muscle as Medicine: Skeletal Muscle Mass and 10-Year Cardiovascular Risk — What the ATTICA … Continue reading →
Posted in Aging, Clinical & Theoretical, Complementary - Alternative Medicine, epigenetics, Events, Fifth Avenue Concierge Medicine, Health, Lifestyle Psychiatry, metabolic, Neuropsychiatry of Affluence, News, Psychiatry/Neurology, Psychological Resilience
|
Tagged ATTICA study, BDNF, body composition, cardiovascular disease, Inflammation, Insulin Resistance, longevity, muscle mass and heart health, myokines, neuropsychiatry, preventive psychiatry, resistance training, sarcopenia, skeletal muscle mass, vascular depression
|